Vir Biotechnology (VIR) Goodwill & Intangibles (2018 - 2026)

Vir Biotechnology has reported Goodwill & Intangibles for 9 years, with the latest figure at $24.7 million in Q1 2026.

• Quarterly Goodwill & Intangibles fell 1.18% year-over-year to $24.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.7 million (down 1.18% YoY) and the FY2025 annual result came in at $24.8 million, down 1.08% from the prior year.
• Goodwill & Intangibles steadied at $24.7 million in Q1 2026 per VIR's latest filing, from $24.8 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $50.1 million in Q1 2022 and troughed at $24.7 million in Q1 2026.
• A 5-year average of $37.3 million and a median of $39.4 million in 2024 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles declined 1.05% in 2022, then plunged 36.57% in 2024.
• Over 5 years, Goodwill & Intangibles stood at $49.7 million in 2022, then decreased by 20.51% to $39.5 million in 2023, then sank by 36.57% to $25.1 million in 2024, then declined by 1.08% to $24.8 million in 2025, then declined by 0.29% to $24.7 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $24.7 million, $24.8 million, and $24.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.